Clinical trial
Raltegravir Pharmacokinetics and Safety in Neonates
NCT01828073 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Raltegravir Pharmacokinetics and Safety in Neonates
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 19, 2011
- Completion date
- April 23, 2018
- Enrollment
- 40 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.